An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Material Removal
Based on the social media company, the service has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.
Within minutes of entering one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.
Item Information and Costs
Within these groups, messages display black plastic packages with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly serious health risks”.
